The structural basis for imatinib resistance in chronic myeloid leukaemia (CML) involves the emergence of imatinib-resistant BCR-ABL point mutations; mutations are usually those that impair drug ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Description The transaction expands SLRHC’s existing relationship with the Company’s principals and related businesses. Proceeds of the credit facility were used to refinance existing debt and provide ...
ORLANDO, Fla., April 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the ...
Brian Cuttic, CEO, ABL, at eCapital commented, “This deal is noteworthy as it highlights our team's commitment to providing alternative financial solutions for businesses facing challenges with ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback